TrialCardiovascular research2025

First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1.

Milind Y Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.